2-Halo-6-O-substituted ketolide derivatives
    2.
    发明授权
    2-Halo-6-O-substituted ketolide derivatives 失效
    2-卤代-6-O-取代的酮内酯衍生物

    公开(公告)号:US6124269A

    公开(公告)日:2000-09-26

    申请号:US154294

    申请日:1998-09-16

    IPC分类号: C07H17/08 A61K31/70

    CPC分类号: A61K31/7048 C07H17/08

    摘要: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.

    摘要翻译: 具有抗菌活性的新型2-卤代-6-O-取代的酮内酯衍生物及其药学上可接受的盐和酯,其具有包含治疗有效量的本发明化合物与药学上可接受的载体的组合物的组合物,治疗细菌的方法 通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物及其制备方法的感染。

    3-'N-modified 6-O-substituted erythromycin ketolide derivatives having
antibacterial activity
    5.
    发明授权
    3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity 有权
    具有抗菌活性的3-N改性的6-O-取代的红霉素酮内酯衍生物

    公开(公告)号:US06034069A

    公开(公告)日:2000-03-07

    申请号:US132256

    申请日:1998-08-11

    IPC分类号: C07H17/08 A61K31/70 C07H1/00

    CPC分类号: C07H17/08

    摘要: Novel 3'-N-modified 6-O-substituted erythromycin ketolide compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.

    摘要翻译: 具有抗细菌活性的新颖的3'-N-修饰的6-O-取代的红霉素酮内酯化合物及其药学上可接受的盐和酯,其具有包含治疗有效量的本发明化合物与药学上可接受的载体的组成的式 作为通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物来治疗细菌感染的方法。

    6,11-bridged erythromycin derivatives
    6.
    发明授权
    6,11-bridged erythromycin derivatives 有权
    6,11桥梁红霉素衍生物

    公开(公告)号:US6046171A

    公开(公告)日:2000-04-04

    申请号:US158459

    申请日:1998-09-22

    IPC分类号: C07H17/08 A61K31/70 C07H1/00

    CPC分类号: C07H17/08

    摘要: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.

    摘要翻译: 具有抗细菌活性的新型6,11-桥接的红霉素化合物及其药学上可接受的盐和酯,其组成包括治疗有效量的本发明化合物与药学上可接受的载体的组合,通过给予 哺乳动物含有治疗有效量的本发明化合物的药物组合物及其制备方法。

    6,9-bridged erythromycin derivatives
    10.
    发明授权
    6,9-bridged erythromycin derivatives 失效
    6,9桥红霉素衍生物

    公开(公告)号:US5780605A

    公开(公告)日:1998-07-14

    申请号:US925582

    申请日:1997-09-08

    CPC分类号: C07H17/08

    摘要: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.

    摘要翻译: 具有抗细菌活性的新型多环红霉素化合物及其药学上可接受的盐和酯具有式(I),(II),图像(III)的组合物,包含治疗有效量的本发明化合物 与药学上可接受的载体的组合,以及通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物来治疗细菌感染的方法。